Related references
Note: Only part of the references are listed.KEGG: integrating viruses and cellular organisms
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2021)
The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma
Krzysztof Kaliszewski et al.
MEDICINE (2019)
Electrical and synaptic integration of glioma into neural circuits
Humsa S. Venkatesh et al.
NATURE (2019)
Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling
Ai-Jing Luo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Isoform-selective activity-based profiling of ERK signaling
Myungsun Shin et al.
CHEMICAL SCIENCE (2018)
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
Haoyu Ren et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
Hai-Zhen Lu et al.
ONCOLOGY LETTERS (2017)
Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer (Withdrawn Publication)
Qing Tang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells
Angad Rao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Molecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a Tibetan Mastiff Dog From Puppies
Dapeng Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors
Chenlei Shi et al.
PLOS ONE (2016)
Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer
Jieun Kang et al.
TUMOR BIOLOGY (2016)
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis
Jiayan Fan et al.
GENOME BIOLOGY (2015)
Expression of c-fos Was Associated with Clinicopathologic Characteristics and Prognosis in Pancreatic Cancer
Jun-Chao Guo et al.
PLOS ONE (2015)
miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer
Jialu Li et al.
PLOS ONE (2015)
FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure, aging, and cancer
Deepa Bhartiya et al.
REPRODUCTION (2015)
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer
Yun Hee Kang et al.
ONCOTARGET (2014)
Rhomboid domain containing 1 inhibits cell apoptosis by upregulating AP-1 activity and its downstream target Bcl-3
Xiaoxia Ren et al.
FEBS LETTERS (2013)
Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation
Ruizan Shi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell
Zhi-Chao Jia et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
E. F. Wagner
ANNALS OF THE RHEUMATIC DISEASES (2010)
Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric Patients
Leighton Stein et al.
THYROID (2010)
Total ERK1/2 activity regulates cell proliferation
Renaud Lefloch et al.
CELL CYCLE (2009)
Comparative Study of Endoscopic Thyroidectomy Versus Conventional Open Thyroidectomy in Papillary Thyroid Microcarcinoma (PTMC) Patients
Jong Ju Jeong et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression
Konstantin Levay et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inducing cancer cell death by targeting transcription factors
R Kim et al.
ANTI-CANCER DRUGS (2003)
Share Paper
